Authors :
Ifeoma Edna Uduji; Uche Godwin Ezema; Joy NkechinyereAnorue; Joshua ChisomOgboeze
Volume/Issue :
Volume 7 - 2022, Issue 6 - June
Google Scholar :
https://bit.ly/3IIfn9N
Scribd :
https://bit.ly/3nB5T86
DOI :
https://doi.org/10.5281/zenodo.6791778
Abstract :
Vaccination against COVID-19 virus is
essential to curb the spread of the virus. Understanding
the nature of adverse events following COVID-19
vaccination will help to improve vaccine reduce spread ,
and promote vaccine safety.
Objective:This study evaluated the adverse events
following vaccination with the different types of COVID19 vaccines, as well as people’s response to such events.
Method:A cross-sectional online survey of persons aged
18 years and above who received at least, one dose of a
COVID-19 vaccinae in Enugu state, Nigeria was
conducted by convenient sampling method. Data was
analysed using SPSS version 25 to determine the
prevalence, characteristics, and predictors of adverse
events following COVID-19 vaccination.
Result:A total of 657 respondents (mean age of 34.9 ± 13
years)completed the survey. Adverse events following
immunization (AEFI) was reported by 29.4% of the
respondents, mostly (96.3%) experienced after receiving
their first dose. Muscle pain, headache, and fever were,
respectively, the most frequently reported AEFI (33.5%,
22.7%, and 20.2%). Common response by the
respondents after experiencing AEFI include taking
paracetamol (36.5%), drinking plenty of water (13.5%),
and application of wet cloth over the area (6.5%). AEFI
were significantly associated with age and education of
the respondents (P-value: 0.013 and 0.020), while no
significant association was established between the type
of vaccine received. Respondents between the age of 18
and 49 years were 1.871 more likely to admit having
experienced AEFI than aged 50 years and above (95%
CI: 1.086 – 3.222). Also, respondents with postgraduate
and post-secondary education were 3.568 (95% CI: 1.348
– 9.541) and 2.688 (95% CI: 1.009 – 7.162) times more
likely to admit that they have experienced AEFI.
Conclusion:It is necessary to improve active surveillance
reporting system for COVID-19 in the state to better
promote vaccine safety, management of cases and more
effective public health advisory.
Keywords :
COVID-19, surveillance, epidemiology, public health preparedness.
Vaccination against COVID-19 virus is
essential to curb the spread of the virus. Understanding
the nature of adverse events following COVID-19
vaccination will help to improve vaccine reduce spread ,
and promote vaccine safety.
Objective:This study evaluated the adverse events
following vaccination with the different types of COVID19 vaccines, as well as people’s response to such events.
Method:A cross-sectional online survey of persons aged
18 years and above who received at least, one dose of a
COVID-19 vaccinae in Enugu state, Nigeria was
conducted by convenient sampling method. Data was
analysed using SPSS version 25 to determine the
prevalence, characteristics, and predictors of adverse
events following COVID-19 vaccination.
Result:A total of 657 respondents (mean age of 34.9 ± 13
years)completed the survey. Adverse events following
immunization (AEFI) was reported by 29.4% of the
respondents, mostly (96.3%) experienced after receiving
their first dose. Muscle pain, headache, and fever were,
respectively, the most frequently reported AEFI (33.5%,
22.7%, and 20.2%). Common response by the
respondents after experiencing AEFI include taking
paracetamol (36.5%), drinking plenty of water (13.5%),
and application of wet cloth over the area (6.5%). AEFI
were significantly associated with age and education of
the respondents (P-value: 0.013 and 0.020), while no
significant association was established between the type
of vaccine received. Respondents between the age of 18
and 49 years were 1.871 more likely to admit having
experienced AEFI than aged 50 years and above (95%
CI: 1.086 – 3.222). Also, respondents with postgraduate
and post-secondary education were 3.568 (95% CI: 1.348
– 9.541) and 2.688 (95% CI: 1.009 – 7.162) times more
likely to admit that they have experienced AEFI.
Conclusion:It is necessary to improve active surveillance
reporting system for COVID-19 in the state to better
promote vaccine safety, management of cases and more
effective public health advisory.
Keywords :
COVID-19, surveillance, epidemiology, public health preparedness.